-transparent.png){kind=logo}
We have already demonstrated the inhibitory effect of interleukin 1 on thyroglobulin gene expression. Recent availability of thyroid peroxidase cDNA has allowed us to investigate the regulation of thyroid peroxidase gene. Therefore, the regulation of thyroid peroxidase mRNA by interleukin 1 in cultured human thyrocytes was investigated. Thyrocytes dispersed from thyroid tissues from patients with Graves' disease were incubated with TSH with or without recombinant human interleukin 1. Unstimulated human thyrocytes did not contain any detectable thyroid peroxidase mRNA, however, TSH-stimulated thyrocytes expressed four thyroid peroxidase mRNA transcripts (4.0, 3.2, 2.1 and 1.7 kb, respectively). Both interleukin 1 alpha and beta inhibited TSH-induced thyroid peroxidase mRNA in a dose responsive manner; 10(3) U/1 interleukin 1 caused maximal suppression of TSH-induced thyroid peroxidase mRNA level to nearly basal levels. Interleukin 1 also inhibited cAMP analogue 8-bromo-cyclic AMP induced thyroid peroxidase mRNA level. In contrast the gamma-actin mRNA hybridization signal was not altered in control or treated cells. These results demonstrate that interleukin 1 directly inhibits TSH-induced thyroid peroxidase gene expression and provide further evidence for a paracrine role of interleukin 1 as a local inhibitor of thyroid hormone synthesis.
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
March 1991,
Acta endocrinologica,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
June 1989,
The Journal of clinical endocrinology and metabolism,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
October 1985,
Molecular and cellular biology,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
December 1992,
Immunology,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
January 1999,
Endocrine pathology,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
January 1990,
Progress in clinical and biological research,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
May 1987,
The Journal of experimental medicine,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
January 1990,
Chemical research in toxicology,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
January 1996,
Chemical research in toxicology,
K Ashizawa, and
S Yamashita, and
T Tobinaga, and
Y Nagayama, and
H Kimura, and
H Hirayu, and
M Izumi, and
S Nagataki
July 1989,
FEBS letters,
